Subscribe now

Two companies aiming to create an artificial “embryo” by merging the nucleus
of a human cell with a pig egg have abandoned their attempt to patent the
process after a Greenpeace exposé. “It was never our intention to claim
patents that would cover human embryos or human reproductive cloning,” says
Julia Greenstein of BioTransplant in Charlestown, Massachusetts. Both companies
deny the decision was in response to the Greenpeace campaign, but the pressure
group is claiming victory. “These are the first biotech companies to admit
having gone too far in claiming patents on human embryos,” it says in a press…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop